DOD Amyotrophic Lateral Sclerosis, Pilot Clinical Trial Award
The fiscal year 2025 (FY25) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Pilot Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of Amyotrophic Lateral Sclerosis (ALS). Projects may range from phase 1 to small-scale phase 2 trials.
DOD Amyotrophic Lateral Sclerosis, Pilot Clinical Trial Award